Zhang, Y., Zhou, H., Suo, S., Zhuang, J., Yang, L., He, A., . . . Jin, J. Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: Final analysis results from a randomized phase 3 study. Nature Publishing Group.
Chicago Style (17th ed.) CitationZhang, Yi, et al. Evaluation of Gecacitinib Vs Hydroxyurea in Patients with Intermediate-2 or High-risk Myelofibrosis: Final Analysis Results from a Randomized Phase 3 Study. Nature Publishing Group.
MLA (9th ed.) CitationZhang, Yi, et al. Evaluation of Gecacitinib Vs Hydroxyurea in Patients with Intermediate-2 or High-risk Myelofibrosis: Final Analysis Results from a Randomized Phase 3 Study. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.